Sartorius Stedim Biotech (FR:DIM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sartorius Stedim Biotech reported a strong liquidity position in its half-year statement, with a total of 46,292 shares and €2,521,189.91 in cash on their liquidity account as of June 30th, 2024. The company, a key international player in the biopharmaceutical industry, supports the production of biotech medications and has a global presence with a workforce of over 10,600 employees.
For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.